Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2005 1
2006 2
2007 1
2008 1
2009 1
2010 1
2011 3
2012 3
2013 1
2014 2
2015 1
2016 2
2017 2
2018 1
2019 1
2020 1
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
Lübbert M, Wijermans PW, Kicinski M, Chantepie S, Van der Velden WJFM, Noppeney R, Griškevičius L, Neubauer A, Crysandt M, Vrhovac R, Luppi M, Fuhrmann S, Audisio E, Candoni A, Legrand O, Foà R, Gaidano G, van Lammeren-Venema D, Posthuma EFM, Hoogendoorn M, Giraut A, Stevens-Kroef M, Jansen JH, de Graaf AO, Efficace F, Ammatuna E, Vilque JP, Wäsch R, Becker H, Blijlevens N, Dührsen U, Baron F, Suciu S, Amadori S, Venditti A, Huls G; EORTC Leukemia Group, GIMEMA, and German MDS Study Group. Lübbert M, et al. Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9. Lancet Haematol. 2023. PMID: 37914482 Free article. Clinical Trial.
Hepatosplenic T-cell lymphoma: treatment challenges.
Bron D, De Leval L, Michiels S, Wittnebel S; EuroBloodNet for rare diseases. Bron D, et al. Among authors: wittnebel s. Curr Opin Oncol. 2021 Sep 1;33(5):406-411. doi: 10.1097/CCO.0000000000000775. Curr Opin Oncol. 2021. PMID: 34409955 Review.
Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference.
Meert AP, Wittnebel S, Holbrechts S, Toffart AC, Lafitte JJ, Piagnerelli M, Lemaitre F, Peyrony O, Calvel L, Lemaitre J, Canet E, Demoule A, Darmon M, Sculier JP, Voigt L, Lemiale V, Pène F, Schnell D, Lengline E, Berghmans T, Fiévet L, Jungels C, Wang X, Bold I, Pistone A, Salaroli A, Grigoriu B, Benoit D; Critically ill cancer patients consensus conference group. Meert AP, et al. Among authors: wittnebel s. Intensive Care Med. 2021 Oct;47(10):1063-1077. doi: 10.1007/s00134-021-06508-w. Epub 2021 Sep 20. Intensive Care Med. 2021. PMID: 34545440 Free PMC article.
Thyroid nocardiosis: Case report and review of the literature.
Esnault V, Wittnebel S, Pouillon M, Collarino R, Jauréguiberry S, Chachaty E, Gachot B, Wyplosz B. Esnault V, et al. Among authors: wittnebel s. Transpl Infect Dis. 2021 Aug;23(4):e13594. doi: 10.1111/tid.13594. Epub 2021 Mar 11. Transpl Infect Dis. 2021. PMID: 33650134 Review.
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.
Baron F, Efficace F, Cannella L, Willemze R, Vignetti M, Muus P, Marie JP, Ferrero D, Fazi P, La Sala E, Bourhis JH, Fabbiano F, Bosi A, Sborgia M, Martinelli G, Wittnebel S, Trisolini S, Petti MC, Halkes CJM, van der Velden WJFM, de Witte T, Amadori S, Zittoun RA, Suciu S. Baron F, et al. Among authors: wittnebel s. Haematologica. 2020 Jan;105(1):e13-e16. doi: 10.3324/haematol.2019.221333. Epub 2019 May 16. Haematologica. 2020. PMID: 31097634 Free PMC article. No abstract available.
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial).
Rahmé R, Ades L, Thomas X, Guerci-Bresler A, Pigneux A, Vey N, Raffoux E, Castaigne S, Spertini O, Wittnebel S, Marolleau JP, Damaj G, Bordessoule D, Lejeune J, Chevret S, Fenaux P. Rahmé R, et al. Among authors: wittnebel s. Haematologica. 2018 Nov;103(11):e519-e521. doi: 10.3324/haematol.2018.193151. Epub 2018 May 24. Haematologica. 2018. PMID: 29794147 Free PMC article. Clinical Trial. No abstract available.
Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.
de Masson A, Bouaziz JD, Peffault de Latour R, Wittnebel S, Ribaud P, Rubio MT, Micol JB, Suarez F, Nguyen S, Dalle JH, Yakouben K, Robin M, Xhaard A, Adès L, Bourhis JH, Rybojad M, Bagot M, Socié G. de Masson A, et al. Among authors: wittnebel s. Blood. 2012 Dec 13;120(25):5089-90. doi: 10.1182/blood-2012-09-453928. Blood. 2012. PMID: 23243159 Free article. No abstract available.
27 results